Eyes in the pharma and medtech industries are directed to the European Society of Cardiology (ESC) Congress every year to examine the latest clinical trial data, observational study results, and real-word evidence in the cardiology space.
On this episode, the healthcare editorial team unpicks several key trials and trends from this year's event, held from 29 August to 1 September in Madrid.
Data at ESC is from studies evaluating investigational drug or medical device candidates, but also from trials analysing approved therapies.
Pharmaceutical Technology editor Robert Barrie sat down with Abigail Beaney, editor of Clinical Trials Arena, and Ross Law, reporter for Medical Device Network, who both covered the congress, to discuss data presented.
